Revitalist and Wake Network, Inc. will be offering ketamine infusions in the United States as well as psilocybin clinical retreats internationally.
The venture between Revitalist, one of the largest publicly listed, ketamine-focused clinic operations in the United States, and Wake Network, a psilocybin bioscience company, will focus on veterans’ ethical need for access to psychedelic treatments.
Revitalist CEO, Kathryn Walker, stated: “The ability to offer multiple psychedelic options to our clients allows us to continue to expand our operations while maintaining our focus on providing ethical access to timely care.”
Psilocybin and Ketamine have been shown to improve depression, PTSD, suicidality, anxiety, and other conditions that cause loss of life for many of our veterans.
A meta-analysis from the National Institutes of Health reports, “approximately 5 million deaths worldwide are attributable to mood and anxiety disorders each year.”
The UNIT Retreat has been created in an effort to provide quality care in a timely manner with the necessary education tools, research initiatives and psychedelic medicines in order to provide ethical access to those in medical need.
Alongside psilocybin therapy with trained professionals, the retreat will include activities such as equine therapy, canine therapy, art therapy, innovative farming techniques, camaraderie, connecting with nature, yoga, mindful meditation and sound therapy.
Wake CEO, Nick Murray, added: “Partnering with the wonderful team at Revitalist delivers on our commitment to furthering care and research to the mental wellness community internationally, through personalised psychedelic treatments.”
The eight day retreat takes place at the Veteran’s Healing Farm in North Carolina, followed by a five day psilocybin retreat in Jamaica. The inaugural event takes place October 10-17 with a goal to provide follow up retreats each month.
